LUGPA Series

LUGPA Virtual Crossfire Discussion and Debate Series


Presentations


Speakers

  • Kenneth M. Kernen, MD

    Kenneth M. Kernen, MD

    Kenneth M. Kernen, MD

    Director of Clinical Research

    Kenneth M. Kernen, MD, is a partner in, and the director of clinical research for, the Michigan Institute of Urology in Troy. Dr Kernen received his medical degree from Wayne State University School of Medicine in Detroit, Michigan, completed his urologic residency at William Beaumont Hospital in Royal Oak, Michigan, and his urologic oncology fellowship at Baylor College of Medicine in Houston, Texas. He is the chief of urology at William Beaumont Hospital, Troy, where he is also the founding director of the Prostate and Urologic Cancer Multidisciplinary Clinic and clinical chair of the Robotic Surgical Committee. Additionally, he is co-director of the Urology Center for Excellence at Beaumont Health Systems.
  • Daniel J. George, MD

    Daniel J. George, MD

    Daniel J. George, MD

    Professor of Medicine and Surgery, Director, GU Oncology

    Daniel J. George, MD, is a professor of medicine and surgery in the Divisions of Medical Oncology and Urology at Duke University School of Medicine in Durham, North Carolina. He also has appointments in the Duke Clinical Research Institute and the Duke Cancer Institute, where he is the director of genitourinary (GU) oncology. Dr George’s areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis. He leads the Duke site for the Department of Defense Prostate Cancer Clinical Trials Consortium, specializing in Phase I and II studies in prostate cancer. Dr George is an internationally recognized clinical researcher and thought leader in GU malignancies, with over 150 peer-reviewed publications.
  • Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Immediate Past President

    Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 350 clinical trials that focus mainly on GU oncology, has served on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is immediate past president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 150 peer-reviewed publications, several book chapters, and is a peer reviewer for numerous high-impact medical journals. He earned his MD from Duke University Medical School and general surgery/urology residency at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center.